To unlock our long term value, we need the company to be engaged with the medical decision makers running the trials and at the FDA and their foreign counterparts more so than engaging the press IMO. Engaging with the press will make us all feel good but if they aren't able to move the drugs forward it won't matter. I much prefer they focus their attention and energy on the drugs themselves and hopefully they are doing so although it is not a matter of public record until the results happen such as the $7 million order from the DoD. What else is happening behind the scenes that we don't know about? I hope a lot. GLTA and Happy and Safe Thanksgiving to all.